U.S., May 30 -- ClinicalTrials.gov registry received information related to the study (NCT07614620) titled 'Effect of Hypnosis in the Management of Anxiety and Chemo-induced Symptoms in Adolescents and Young Adults With Sarcoma or Germ Cell Tumor and in Young Women With Breast Cancer' on May 18.

Brief Summary: The HYPNO-AJA 2 study is a prospective single-center interventional clinical trial conducted at the Institut Bergonie to evaluate the effectiveness of hypnosis in reducing anxiety and chemotherapy-related symptoms in adolescents, young adults (AYAs), and young women undergoing cancer treatment. The study focuses on patients aged 15-39 with sarcoma or germ cell tumors and women aged 15-49 with breast cancer receiving neoadjuvant chemo...